Patent application number | Description | Published |
20140249090 | PEPTIDES AND PHARMACEUTICAL COMPOSITIONS FOR USE IN THE TREATMENT BY NASAL ADMINISTRATION OF PATIENTS SUFFERING FROM ANXIETY AND SLEEP DISORDERS - The present invention provides peptides for use in a medicament which is administered nasally, wherein the peptide is an agonist of neuropeptide S receptor (NPSR), of the receptor TGR23 and/or of vasopressin receptor-related receptor 1 (VRR1) or for use in the treatment of a patient by causing, promoting or increasing relieve or healing of phobic anxiety, avoidance anxiety, dissociative anxiety such as flashbacks, depersonalization, derealization, intrusions, vegetative symptoms related to anxiety symptoms, especially in panic attacks, in posttraumatic stress disorder, in generalised anxiety disorder and in anxiety accompanying depressive, or psychotic episodes, arousal, awakening, alertness, activity, spontaneous movement, an anxiolytic effect or a combination thereof in the patient, wherein the peptide is administered nasally or for use in the prophylaxis and/or treatment of an anxiety or sleep disorder, especially in any type of hypersomnia like idiopathic hypersomnia, wherein the peptide is administered nasally. Further provided are pharmaceutical compositions for nasal administration comprising at least one of said peptides, uses of said peptide or said pharmaceutical composition. The invention also provides a method for identifying target neurons of a peptide in an animal, wherein the peptide is administered nasally. | 09-04-2014 |
Patent application number | Description | Published |
20110281342 | HAND-HELD DEVICE FOR MEASURING AN ANALYTE CONCENTRATION IN A SAMPLE OF A BODY LIQUID - A hand-held device for measuring an analyte concentration in a sample of a body liquid includes a display means for displaying measured values; a measured-value storage for storing measured values; a measuring unit for generating measured values through measurements of the analyte concentration; a clock; a control unit for generating measured value datasets, each containing a measured value supplied by the measuring unit as well as the date and hour of the measurement by which the measured value was obtained, and for writing them into the measured-value storage; and operating elements that can be actuated by the user to set the clock, in which case the control unit will generate a time-correction dataset indicating the amount and direction of the setting effected. The control unit writes time-correction datasets into the measured-value storage so that a chronologically ordered sequence is generated containing time-correction datasets and measured value datasets. | 11-17-2011 |
20120157806 | REPRESENTATION OF LARGE, VARIABLE SIZE DATA SETS ON SMALL DISPLAYS - A method of enhancing readability of a graph showing glucose values received from a continuous glucose monitoring device (CGM) on the display of a handheld device includes receiving a plurality of CGM glucose values separated by a first fixed time interval. A second fixed time interval at which to display at least a portion of the plurality of CGM glucose values is received. The second fixed time interval is greater than the first fixed time interval. A computer processor of the handheld device determines a characteristic CGM glucose value at a preselected fixed time for each of a sequence of second fixed time intervals within a patient-specified time period. Each characteristic CGM glucose value is derived from two or more received CGM values centered about the preselected fixed time in the corresponding second fixed time interval. The characteristic CGM glucose values for a patient-selected period of time on the display. | 06-21-2012 |
20130338453 | AUTOMATIC RECOGNITION OF KNOWN PATTERNS IN PHYSIOLOGICAL MEASUREMENT DATA - A method for analysing physiological measurement values of a user is proposed. The method comprises at least one data acquisition step, wherein, during the data acquisition step, physiological measurement values of the user are acquired at different measurement times and stored in a measurement data record; at least one pattern selection step, wherein, during the pattern selection step, measurement values acquired during one comparison time interval are selected as at least one comparison pattern; and at least one pattern recognition step, wherein, during the pattern recognition step, patterns corresponding to the comparison pattern are sought after in the measurement data record. | 12-19-2013 |
20140068487 | Computer Implemented Methods For Visualizing Correlations Between Blood Glucose Data And Events And Apparatuses Thereof - Methods and apparatuses for visualizing correlations between blood glucose data and events are disclosed. The methods and apparatus can include presenting an event analysis window on a display communicatively coupled to one or more processors. The event analysis window can include an event type control positioned within the event analysis window and a graphical window positioned within the event analysis window. A plurality of continuous glucose monitoring traces can be plotted within the graphical window. Bolus icons each indicative of a bolus amount and a bolus time can be presented within the event analysis window. Each of the bolus icons can include a bolus indication object that is aligned with the bolus ordinate axis within the graphical window, a bolus time indication object that is aligned with the time abscissa axis within in the graphical window, and a bolus symbol that is presented outside of the graphical window. | 03-06-2014 |
20140249778 | HAND-HELD DEVICE FOR MEASURING AN ANALYTE CONCENTRATION IN A SAMPLE OF A BODY LIQUID - A hand-held device for measuring an analyte concentration in a sample of a body liquid includes a display means for displaying measured values; a measured-value storage for storing measured values; a measuring unit for generating measured values through measurements of the analyte concentration; a clock; a control unit for generating measured value datasets, each containing a measured value supplied by the measuring unit as well as the date and hour of the measurement by which the measured value was obtained, and for writing them into the measured-value storage; and operating elements that can be actuated by the user to set the clock, in which case the control unit will generate a time-correction dataset indicating the amount and direction of the setting effected. The control unit writes time-correction datasets into the measured-value storage so that a chronologically ordered sequence is generated containing time-correction datasets and measured value datasets. | 09-04-2014 |
20160097760 | METHOD AND APPARATUS FOR CHARACTERISTIC MONITORING IN CONJUNCTION WITH A MODE OF CONTINUOUSLY MEASURED BLOOD GLUCOSE VALUES AND COMPUTER PROGRAM PRODUCT - A method for characteristic monitoring in conjunction with a mode of continuously measured blood glucose values, in a monitor apparatus provided with a processor, a memory, a data interface, an input device, and a signaling device, the method comprising: providing a first set of event specific characteristics assigned to a first event, the first set of event specific characteristics being different from a second set of event specific characteristics assigned to a second event which is different from the first event, receiving blood glucose value data performing a safety check by comparing the first set of event specific characteristics to present characteristics derived from the blood glucose value data and/or the characteristic values, generating a warning signal or generating a safety signal, and outputting an output signal. A monitor apparatus is also disclosed. | 04-07-2016 |
Patent application number | Description | Published |
20100197280 | TRANSCEIVER WITH MESSAGE NOTIFICATION - A transceiver, comprising an interface for receiving at least one message, a display unit provided to assume at least one switched-on operating state and at least one switched-off operating state, a message indicator indicating a receipt of a message by a unit of a signal, independent of the operating state of the display unit, wherein the message is associated with at least one message parameter, and a unit for evaluating the message parameter with the signal provided as a function of evaluation of the message parameter. | 08-05-2010 |
20150156305 | TRANSCEIVER WITH MESSAGE NOTIFICATION - A transceiver, comprising an interface for receiving at least one message, a display unit provided to assume at least one switched-on operating state and at least one switched-off operating state, a message indicator indicating a receipt of a message by a unit of a signal, independent of the operating state of the display unit, wherein the message is associated with at least one message parameter, and a unit for evaluating the message parameter with the signal provided as a function of evaluation of the message parameter. | 06-04-2015 |
Patent application number | Description | Published |
20110193084 | FORMULATIONS COMPRISING A MIXTURE OF ZNO CUBANES AND PROCESS USING THEM TO PRODUCE SEMICONDUCTIVE ZNO LAYERS - The present invention relates to formulations comprising a) at least two different ZnO cubanes of which at least one ZnO cubane is present in solid form under SATP conditions and at least one ZnO cubane is present in liquid form under SATP conditions, and b) at least one solvent, to processes for producing semiconductive ZnO layers from these formulations, to the use of the formulations for producing electronic components and to the electronic components themselves. | 08-11-2011 |
20110309313 | COMPOSITIONS CONTAINING INDIUM ALKOXIDE, METHOD FOR THE PRODUCTION THEREOF, AND USE THEREOF - The present invention relates to a liquid indium alkoxide-containing composition comprising at least one indium alkoxide and at least three solvents L | 12-22-2011 |
20110315982 | METHOD FOR PRODUCING SEMICONDUCTING INDIUM OXIDE LAYERS, INDIUM OXIDE LAYERS PRODUCED ACCORDING TO SAID METHOD AND THEIR USE - The present invention relates to a process for producing semiconductive indium oxide layers, in which a substrate is coated with a liquid, anhydrous composition comprising a) at least one indium alkoxide and b) at least one solvent, optionally dried and thermally treated at temperatures greater than | 12-29-2011 |
20120181488 | METHOD FOR THE PRODUCTION OF METAL OXIDE-CONTAINING LAYERS - The invention relates to a liquid-phase method for producing metal oxide-containing layers from nonaqueous solution. In said method, an anhydrous composition containing i) at least one metal oxo-alkoxide of generic formula M | 07-19-2012 |
20120202318 | METHOD FOR THE PRODUCTION OF LAYERS CONTAINING INDIUM OXIDE - The present invention relates to a liquid phase process for producing indium oxide-containing layers from nonaqueous solution, in which an anhydrous composition containing at least one indium oxo alkoxide of the generic formula M | 08-09-2012 |
20120289728 | PROCESS FOR THE PREPARATION OF INDIUM CHLORDIALKOXIDES - The present invention relates to a process for the preparation of indium(III) halodialkoxides of the generic formula InX(OR) | 11-15-2012 |
20130104773 | INDIUM OXOALKOXIDES FOR PRODUCING COATINGS CONTAINING INDIUM OXIDE | 05-02-2013 |
20130116463 | INDIUM OXOALKOXIDES FOR PRODUCING COATINGS CONTAINING INDIUM OXIDE - The present invention relates to halogenated indium oxo alkoxides of the generic formula In | 05-09-2013 |
20130221352 | PROCESS FOR PRODUCING INDIUM OXIDE-CONTAINING LAYERS - The present invention relates to a liquid phase process for producing indium oxide-containing layers, in which a coating composition preparable from a mixture comprising at least one indium oxide precursor and at least one solvent and/or dispersion medium, in the sequence of points a) to d), a) is applied to a substrate, and b) the composition applied to the substrate is irradiated with electromagnetic radiation, c) optionally dried and d) converted thermally into an indium oxide-containing layer, where the indium oxide precursor is an indium halogen alkoxide of the generic formula InX(OR) | 08-29-2013 |
Patent application number | Description | Published |
20110109319 | TEST CONFIGURATION FOR THE IMPULSE VOLTAGE TEST OF ELECTRIC HIGH-VOLTAGE COMPONENTS - The embodiments relate to a test configuration for an impulse voltage test of electric high-voltage components with a lightning generator. The lightning generator can be moved between a first horizontal position within a cuboid container, and a vertical position relative to the container. A movement between the two positions includes a pivoting movement about a rotational axis. The proofing movement is transverse to the longitudinal direction of the lightning generator. The container can be closed at the top by at least one moveable cover. | 05-12-2011 |
20110121853 | TEST ARRANGEMENT FOR AC VOLTAGE TESTING OF ELECTRICAL HIGH VOLTAGE COMPONENTS - A test arrangement is provided for AC voltage testing of high voltage components including at least one inverter, at least one test transformer, at least one high-voltage inductor and at least one further high voltage component arranged as test components in a common cuboid container. The at least one high-voltage inductor is movable at least partially out of the container through at least one opening on a boundary surface of the container, by means of a movement apparatus. The at least one further high voltage component is movable within the cuboid container from a transport position to a working position. | 05-26-2011 |
20110128013 | TEST ARRANGEMENT FOR AC TESTING OF ELECTRICAL HIGH VOLTAGE COMPONENTS - A test arrangement is provided for AC testing of electrical high voltage components including at least one inverter, at least one test transformer and at least one high voltage inductor arranged as test components in a common cuboid container. The at least one high voltage inductor runs along an imaginary axis and may be at least partly removed from the container through at least one opening in a limit face of the container by means of a movement device. The at least one high voltage inductor includes has integrated surge protection. | 06-02-2011 |
20110133749 | TEST ARRANGEMENT FOR AC TESTING OF ELECTRICAL HIGH VOLTAGE COMPONENTS - A test arrangement is provided for AC testing of electrical high voltage components including at least one inverter, at least one test transformer and at least one high-voltage inductor arranged as test components in a common cuboid container. The at least one high-voltage inductor is at least partly removable from the container through at least one opening on a boundary surface of the container by means of a movement apparatus. | 06-09-2011 |
20110133754 | TEST ARRANGEMENT FOR IMPULSE VOLTAGE TESTING OF ELECTRICAL HIGH-VOLTAGE COMPONENTS - Exemplary embodiments are directed to a test arrangement for testing surge voltage in electrical high voltage components with a surge voltage generator and a voltage distributor. The surge voltage generator and voltage distributor have a tower-like structure with a first and a second structure end. A rectangular container is connected to the first and second structure and includes a first and a second container end. At least one of the surge voltage generator and the voltage distributor are movable between a first substantially horizontal position inside the container and a substantially vertical position relative to the container. Each movement between the two positions involves a pivot motion about a rotational axis perpendicular to the longitudinal direction of the surge voltage generator. | 06-09-2011 |
Patent application number | Description | Published |
20140239990 | TESTING CONTAINER - A testing container includes a right-parallelepiped-like container, electrical components of a transformer test system which are arranged in the container and which represent a respective heat source during a testing operation, and a cooling system including at least one heat exchanger. In addition, the testing container includes a movement apparatus configured to move the at least one heat exchanger from a transport position within the container into a working position which is located at least partially outside the container. Thus, the at least one heat exchanger is movable by means of the movement apparatus from the transport position within the container into the working position which is located at least partially outside the container. | 08-28-2014 |
20140240901 | HIGH-VOLTAGE TRANSFORMER MODULE - A high-voltage transformer module includes a transformer core including at least one winding, and a mechanical supporting structure having the transformer core integrated permanently therein. The mechanical supporting structure has corner points arranged in the form of a right-parallelepiped. The corner points are in the form of load transfer points and are arranged corresponding to the dimensions of a CSC (International Convention for Safe Containers) container. | 08-28-2014 |
20150109017 | TEST SYSTEM FOR HIGH-VOLTAGE COMPONENTS - An exemplary test arrangement for in-situ partial discharge measurements in distribution transformers has at least one test system with a plurality of test components including: an AC voltage source for producing a variable test voltage with a measuring apparatus for recording current pulses caused by partial discharge and with an evaluation apparatus for the recorded current pulses, a grounded test container in which at least some of the test components are arranged, and a distribution transformer connected to the AC voltage source as a test object. The test object is arranged on insulation means for electrically insulating the test object. Those parts of the test object which are grounded during normal operation being connected at least to the potential of the grounded test container. | 04-23-2015 |
Patent application number | Description | Published |
20090050262 | Production of Dosing Molds from Active Substance-Containing Melts - Disclosed is a method for producing dosing molds, according to which two separating films ( | 02-26-2009 |
20100240672 | MELT-PROCESSED IMATINIB DOSAGE FORM - The invention provides a dosage form, comprising a melt-processed mixture of (a) a pharmaceutically effective amount of imatinib or a salt thereof, (b) at least one polymeric binder, and (c) at least one pharmaceutically acceptable non-ionic surfactant. The invention provides imatinib dosage forms with high drug loading which can be prepared in a simple and efficient manner, imatinib dosage forms from which the active principle is released in an essentially pH-independent fashion, and extended release imatinib dosage forms. | 09-23-2010 |
20100297194 | FORMULATION FOR ORAL ADMINISTRATION OF APOPTOSIS PROMOTER - An orally deliverable pharmaceutical composition comprises as a sole or first active ingredient a compound of Formula I defined herein or a pharmaceutically acceptable salt thereof, for example ABT-263 free base or ABT-263 bis-HCl salt, dispersed, in a free base equivalent amount of at least about 2.5% by weight of the composition, in a pharmaceutically acceptable carrier; wherein said active ingredient is in solid-state form and/or the composition further comprises, dispersed in the carrier, a pharmaceutically acceptable heavier-chalcogen antioxidant in an amount effective to inhibit oxidation of the active ingredient at a thioether linkage thereof. The composition is suitable for oral administration to a subject in need thereof for treatment of a disease characterized by overexpression of one or more anti-apoptotic Bcl-2 family proteins, for example cancer. | 11-25-2010 |
20100310648 | PHARMACEUTICAL DOSAGE FORM FOR ORAL ADMINISTRATION OF A BCL 2 FAMILY INHIBITOR - The invention relates to a pharmaceutical dosage form which comprises a solid dispersion product comprising N-(4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohex-1-en-1-yl)methyl)piperazin-1-yl)benzoyl)-4-(((1R)-3-(morpholin-4-yl)-1-((phenylsulfanyl)methyl)propyl)amino)-3-((trifluoromethyl)sulfonyl)benzenesulfonamide or a salt, hydrate or solvate thereof, at least one pharmaceutically acceptable polymer, and at least one pharmaceutically acceptable solubilizer. The invention is further directed to processes for preparing the pharmaceutical dosage form and to use of the dosage form for treating proliferative disorders. | 12-09-2010 |
20120001361 | PREPARATION OF COMPOSITIONS WITH ESSENTIALLY NONCRYSTALLINE EMBEDDED MACROLIDE ANTIBIOTICS - A description is given of a process for the preparation of a pharmaceutical composition of a macrolide antibiotic in essentially noncrystalline form, in which the macrolide antibiotic, a water-swellable polymer and a proton donor are blended in an extruder in the presence of water and forced through a die, the ratio by weight of the sum of macrolide antibiotic, water-swellable polymer and proton donor to water being at least 1:1. The macrolide antibiotic is preferably clarithromycin and the water-swellable polymer is preferably chosen from crosslinked polyvinylpyrrolidone, crosslinked sodium carboxymethylcellulose and crosslinked polyacrylic acid. | 01-05-2012 |